
Spanish AI Medical Imaging Startup Quibim Secures $50M to Expand in U.S
The company’s flagship products, including QP-Prostate (for prostate cancer detection), QP-Brain (for neurological diseases), and QP-Liver (for liver disease diagnosis), are already FDA-cleared or under regulatory review in the U.S.